WB [WEIBO] 6-K: (Original Filing)

[Weibo Reports Second Quarter 2015 Results BEIJING, August 18, 2015—Weibo Corporation (“Weibo” or the “Company”) (NASDAQ: WB), a leading social media in China, today announced its unaudited financial results for the quarter ended June 30, 2015. Second Quarter 2015 Highlights · · · · · · · “Weibo’s MAU growth continues to be robust, reaching 212 million in June, as]

FFHL [Fuwei Films] 6-K: (Original Filing)

[Fuwei Films Announces Its Unaudited Financial Results for the Second Quarter of 2015 -Teleconference to be Held on Friday, August 21, 2015 at 9:00 am EDT- BEIJING, August 20, 2015 Second Quarter 2015 Financial Highlights § Net sales during the second quarter ended June 30, 2015 were RMB66.7 million or US$10.8 million. § Sales of specialty films accounted for 31.9%] [No. 387 Dongming Road Weifang Shandong People’s Republic of China, Postal Code: 261061 x ¨ Form 20-F ¨ 101(b)(1): ¨ 101(b)(7): ¨ x Yes EXPLANATORY NOTE On August 20, 2015, the Company announced its unaudited consolidated financial results for the six-month period ended June 30, 2015. 2 FUWEI FILMS (HOLDINGS) CO., LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS AS OF]

By | 2016-03-19T02:18:48+00:00 August 20th, 2015|Categories: Chinese Stocks, FFHL, SEC Original|Tags: , , , , , |0 Comments

WB [WEIBO] 6-K: Weibo Reports Second Quarter 2015 Results BEIJING, August

[Weibo Reports Second Quarter 2015 Results BEIJING, August 18, 2015—Weibo Corporation (“Weibo” or the “Company”) (NASDAQ: WB), a leading social media in China, today announced its unaudited financial results for the quarter ended June 30, 2015. Second Quarter 2015 Highlights · · · · · · · “Weibo’s MAU growth continues to be robust, reaching 212 million in June, as]

FFHL [Fuwei Films] 6-K: Fuwei Films Announces Its Unaudited Financial Results for

[Fuwei Films Announces Its Unaudited Financial Results for the Second Quarter of 2015 -Teleconference to be Held on Friday, August 21, 2015 at 9:00 am EDT- BEIJING, August 20, 2015 Second Quarter 2015 Financial Highlights § Net sales during the second quarter ended June 30, 2015 were RMB66.7 million or US$10.8 million. § Sales of specialty films accounted for 31.9%] [No. 387 Dongming Road Weifang Shandong People’s Republic of China, Postal Code: 261061 x ¨ Form 20-F ¨ 101(b)(1): ¨ 101(b)(7): ¨ x Yes EXPLANATORY NOTE On August 20, 2015, the Company announced its unaudited consolidated financial results for the six-month period ended June 30, 2015. 2 FUWEI FILMS (HOLDINGS) CO., LTD. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS AS OF]

By | 2016-03-19T02:19:46+00:00 August 20th, 2015|Categories: Chinese Stocks, FFHL, Webplus ver|Tags: , , , , , |0 Comments

SINA [SINA] 6-K: (Original Filing)

[SINA Reports Second Quarter 2015 Financial Results SHANGHAI, China—August 18, 2015— Second Quarter 2015 Highlights · · · “We are delighted that SINA has further implemented its vertical and mobile strategies and launched a set of constructive corporate actions to better leverage SINA’s brand equity, capture business opportunities and give momentum to the capital market,” said Charles Chao, Chairman and]

By | 2016-03-11T02:54:51+00:00 August 20th, 2015|Categories: Chinese Stocks, SEC Original, SINA|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q/A: (Original Filing)

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q1214a1ex32i_tianyinphar.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q1214a1ex32ii_tianyinphar.htm CERTIFICATION]

By | 2016-03-19T14:14:49+00:00 August 20th, 2015|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

SINA [SINA] 6-K: SINA Reports Second Quarter 2015 Financial Results SHANGHAI,

[SINA Reports Second Quarter 2015 Financial Results SHANGHAI, China—August 18, 2015— Second Quarter 2015 Highlights · · · “We are delighted that SINA has further implemented its vertical and mobile strategies and launched a set of constructive corporate actions to better leverage SINA’s brand equity, capture business opportunities and give momentum to the capital market,” said Charles Chao, Chairman and]

By | 2016-03-11T02:55:50+00:00 August 20th, 2015|Categories: Chinese Stocks, SINA, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q/A:

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this amendment to quarterly report on Form 10-Q for the period ended December 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q1214a1ex32i_tianyinphar.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q1214a1ex32ii_tianyinphar.htm CERTIFICATION]

By | 2016-03-19T14:16:48+00:00 August 20th, 2015|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

CISG [CNINSURE] 6-K: (Original Filing)

[IR-197 Second Quarter 2015 Unaudited Financial Results CNinsure Reports — Quarterly Net Revenues Beat Guidance, Up 32.1% CISG 1 GUANGZHOU, China, August 19, 2015 (GLOBE NEWSWIRE) -- CNinsure Inc, (Nasdaq: Financial Highlights for Second quarter of 2015 (RMB in thousands, except per ADS) +2015Q2 +2014Q2 CHANGE % + Total net revenues 672,060 508,853 32.1 % Operating income 22,295 18,717 19.1] []

By | 2016-03-21T02:11:52+00:00 August 20th, 2015|Categories: Chinese Stocks, CISG, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar